(New York Times) – The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

Two top officials at Cassava Sciences — a small pharmaceutical company in Austin, Texas, embroiled in years of controversy over a proposed Alzheimer’s drug — have resigned. (Read More)